resubmission applications / Renewal applications / targeted revision applications / health delivery systems / health services / clinical service delivery systems / cancer clinical trial protocols / clinical networks / ancillary services / /
MedicalCondition
Successful cancer / single transdisciplinary cancer / Cancer / TYPES OF CENTERS Cancer / rare cancers / ESSENTIAL CHARACTERISTICS OF NCI DESIGNATED CANCER CENTERS / institutional cancer / NCI-designated cancer / formalized cancer / as one cohesive cancer / peer-reviewed cancer / Comprehensive cancer / clearly defined cancer / /
MedicalTreatment
CLINICAL PROTOCOL / clinical research protocols / /
Organization
National Institute of Health / office of Cancer Centers / Internal Review Board / CANCER CENTER / NCI Subcommittee / National Cancer Advisory Board / Cancer Center Administration / /CLINICAL TRIALS OFFICE / Health/ DHHS National Cancer Institute office of Cancer Centers / /
Position
Investigator / project director/principal investigator / program director / MAJOR RESEARCH AREAS OF CANCER CENTERS / Director / director of their grant / director oversight / MAJOR RESEARCH AREAS OF CANCER CENTERS AND TYPES OF INTERACTIONS An NCI-designated cancer center / center director / qualified scientist and administrator / /
Product
SPOREs / /
ProvinceOrState
Maryland / /
PublishedMedium
Cancer Research / the NIH guide / /
Technology
34 2.10 CLINICAL PROTOCOL / 2.11 PROTOCOL / 37 NUMBER OF PROTOCOLS / governing cancer clinical trial protocols / clinical research protocols / /
Policies and Guidelines Relating To the P30 Cancer Center Support Grant (For applications submitted on or after January 25, 2013) National Institutes of Health/ DHHS National Cancer Institute